Разделы презентаций


Experimental animal research in Almazov Centre Michael Galagudza 25.02.16,

Содержание

Division of Experimental Physiology and Pharmacology – 10 employees; Animal house – 6 employees;Laboratory of Myocardial Metabolism – 8 employees;Laboratory of Microcirculation – 8 employees;Laboratory of Mathematical Modeling – 8 employees;Laboratory

Слайды и текст этой презентации

Слайд 1Experimental animal research in Almazov Centre
Michael Galagudza
25.02.16, Almazov Centre,

St-Petersburg

Experimental animal research in Almazov Centre Michael Galagudza25.02.16, Almazov Centre, St-Petersburg

Слайд 2Division of Experimental Physiology and Pharmacology – 10 employees;
Animal

house – 6 employees;
Laboratory of Myocardial Metabolism – 8 employees;
Laboratory

of Microcirculation – 8 employees;
Laboratory of Mathematical Modeling – 8 employees;
Laboratory of Nanotechnology – 6 employees;
Laboratory of Systemic Hemodynamics – 6 employees;
Laboratory of Bioprosthetics and Cardioprotection – 6 employees.
TOTALLY 58 employees

Structure of the Institute of Experimental Medicine

Division of Experimental Physiology and Pharmacology – 10 employees; Animal house – 6 employees;Laboratory of Myocardial Metabolism

Слайд 3Январь 2013 г.
Renovation of the building of Institute of Experimental

Medicine
December 2012
May 2013
December 2013
June 2014

Январь 2013 г.Renovation of the building of Institute of Experimental MedicineDecember 2012May 2013December 2013June 2014

Слайд 4Maintenance of 2000 mice and 1000 rats in the individually

ventilated cages
Maintenance of immune deficient animals and genetically engineered animals

(transgenic, knockout, …)

New building of the Institute: animal house

Maintenance of 2000 mice and 1000 rats in the individually ventilated cagesMaintenance of immune deficient animals and

Слайд 5ABSL-1 biosafety level
Individually ventilated cages
Cleanrooms of 8th and 6th classes

according to ISO definition
Barrier system (showers, pressure gradients, sticky pads,

etc.
Backing up all main technological processes
The SPF animals are received from certified breeders only
External health monitoring program
Sterilization of all materials coming to the clean area
Regular education/training of the personnel

The technological principles of SPF barrier facility

ABSL-1 biosafety levelIndividually ventilated cagesCleanrooms of 8th and 6th classes according to ISO definitionBarrier system (showers, pressure

Слайд 6How do we work ?
Surgery room
Animal holding room

How do we work ?Surgery roomAnimal holding room

Слайд 7Aseptic surgical models in chronic experiments
Complete characterization of cardiovascular system:
-

Echo
MRI
LDF
- cardiac catheterization (PV loops)
- isolated heart, in

vitro vessel reactivity
Assessment of acute and chronic toxicity
Investigation of specific activity of the drugs
Specific forms of toxicity

New building of the Institute: novel opportunities

Aseptic surgical models in chronic experimentsComplete characterization of cardiovascular system:- Echo MRI LDF- cardiac catheterization (PV loops)-

Слайд 8Experience and expertise
Equipment and techniques
Prerequisites
Surgical models + physiological monitoring, ECG,

Echo, MRI, PV loops, isolated heart, …
Outcomes
Implementation
Modular principle in planning

and designing research projects
Experience and expertiseEquipment and techniquesPrerequisitesSurgical models + physiological monitoring, ECG, Echo, MRI, PV loops, isolated heart, …OutcomesImplementationModular

Слайд 9Targeted drug delivery to the ischemic muscle with nanocarriers (particularly,

magnetic field-guided delivery);
Pharmacological and non-pharmacological neuroprotection: harnessing the potential of

cerebral pre- and postconditioning;
Stimulation of myocardial regeneration with mesenchymal stem cells and apoptotic bodies;
Pharmacological cardioprotection using necroptosis inhibitors
(Auto)fluorescent imaging of ischemia-reperfusion injury

Main current research projects

Targeted drug delivery to the ischemic muscle with nanocarriers (particularly, magnetic field-guided delivery);Pharmacological and non-pharmacological neuroprotection: harnessing

Слайд 10Heart-targeted delivery of cardioprotective drugs: focusing pharmacological postconditioning on the

injury
Multifunctional nano-carrier
Target cell
Intact cell
Expression of injury marker

Heart-targeted delivery of cardioprotective drugs: focusing pharmacological postconditioning on the injuryMultifunctional nano-carrierTarget cellIntact cellExpression of injury marker

Слайд 11Potentiation of infarct-limiting effect of adenosine after its adsorption on

the surface of silica nanoparticles
** - р

- р<0,05 vs Ado

I.v. infusion of ADO or ADO+SNPs (10 min)

Infarct size

30-min ischemia

Reperfusion 90 min

Galagudza et al., Int J Nanomed 2012; 7:1671–78

Potentiation of infarct-limiting effect of adenosine after its adsorption on the surface of silica nanoparticles** - р

Слайд 12Linkermann, Green. N Engl J Med 2014; 370:455-465
Necrosome activators

as therapeutic target

Linkermann, Green. N Engl J Med 2014; 370:455-465 Necrosome activators as therapeutic target

Слайд 13Cardioprotective effects of necroptosis inhibitors necrostatin-1 and -5
Dmitriev et al.,

Eur Heart J, 2013; 34: 1021 (abstract)

Cardioprotective effects of necroptosis inhibitors necrostatin-1 and -5Dmitriev et al., Eur Heart J, 2013; 34: 1021 (abstract)

Слайд 14Cardioprotective effects of necroptosis inhibitor necrostatin-7 in the in vivo

model
3 weeks
Dmitriev et al., Circulation 2014; 130: A17348 (abstract)

Cardioprotective effects of necroptosis inhibitor necrostatin-7 in the in vivo model3 weeksDmitriev et al., Circulation 2014; 130:

Слайд 15Reduced form: NADH
Oxidized form: NAD+
240
280
320
360
0
4
8
12
16
Wavelength, nм
Absorbance
NADH
NAD+
Ischemia
Ischemia-induced imbalance between

NAD and NADH can influence the level of autofluorescence

Reduced form: NADH Oxidized form: NAD+ 2402803203600481216Wavelength, nмAbsorbanceNADHNAD+IschemiaIschemia-induced imbalance between NAD and NADH can influence the level

Слайд 16The dynamics of autofluorescence in repeated episodes of myocardial ischemia
Visualization

of early signs of myocardial injury in ischemia-reperfusion using NADH

autofluorescence
The dynamics of autofluorescence in repeated episodes of myocardial ischemiaVisualization of early signs of myocardial injury in

Слайд 17Intravital and post-mortem visualization of ischemic-reperfused area of the heart

with cardiogreen and TTC
Sonin et al., 2016 (in preparation)

Intravital and post-mortem visualization of ischemic-reperfused area of the heart with cardiogreen and TTC Sonin et al.,

Слайд 18Endovascular occlusion of middle cerebral artery
Ischemic area
(Evans blue)
Necrotic area

(TTC staining)
Silicone-processed prolene (4-0) filament
Filament position

Endovascular occlusion of middle cerebral arteryIschemic area (Evans blue)Necrotic area (TTC staining)Silicone-processed prolene (4-0) filament Filament position

Слайд 19Shmonin et al. Int J Stroke. 2014; 9:793-801.
The characteristics of

cerebral infarction in five different models of MCA ligation through

craniectomy
Shmonin et al. Int J Stroke. 2014; 9:793-801.The characteristics of cerebral infarction in five different models of

Слайд 20Zukhurova et al., Phytother Res 2013; 27(9): 1282-7
L-theanine administration results

in neuroprotection and prevents glutamate receptor agonist-mediated injury

Zukhurova et al., Phytother Res 2013; 27(9): 1282-7L-theanine administration results in neuroprotection and prevents glutamate receptor agonist-mediated

Слайд 21Mice – 17 000
Rats – 5 000
Frogs (Xenopus

laevis) – 250
Fish (Danio rerio) – 34 000
Mini-pigs – 10
Monkeys
Molecular

imaging
Cell biology/cytotoxicology
Molecular biology and genetics
Toxicology and carcinogenesis
Biochemistry
Morphology
Pharmacology and Physiology
Chemistry and Analysis
Embryogenesis
Immunotoxicology
Microbiology
Transgenic core facility

Divisions:

Animals:

New preclinical research center – 10 000 m2

Mice – 17 000 Rats – 5 000 Frogs (Xenopus laevis) – 250Fish (Danio rerio) – 34

Слайд 22Welcome to the Institute of Experimental Medicine!

Welcome to the Institute of Experimental Medicine!

Обратная связь

Если не удалось найти и скачать доклад-презентацию, Вы можете заказать его на нашем сайте. Мы постараемся найти нужный Вам материал и отправим по электронной почте. Не стесняйтесь обращаться к нам, если у вас возникли вопросы или пожелания:

Email: Нажмите что бы посмотреть 

Что такое TheSlide.ru?

Это сайт презентации, докладов, проектов в PowerPoint. Здесь удобно  хранить и делиться своими презентациями с другими пользователями.


Для правообладателей

Яндекс.Метрика